Bristol-Myers Squibb
BMY
#188
Rank
HK$877.00 B
Marketcap
HK$430.80
Share price
-2.40%
Change (1 day)
0.49%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): HK$23.15

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is HK$23.15. In 2024 the company made an earnings per share (EPS) of -HK$34.46 a decrease over its 2023 EPS that were of HK$30.25.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$23.15-167.19%
2024-HK$34.46-213.92%
2023HK$30.2530.2%
2022HK$23.23-6.04%
2021HK$24.73-179.29%
2020-HK$31.18-281.37%
2019HK$17.19-27.21%
2018HK$23.62
2016HK$20.82175.26%
2015HK$7.56-19.83%
2014HK$9.43-22.44%
2013HK$12.1634.48%
2012HK$9.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.41-42.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.20 155.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.96 590.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.38 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$28.89 24.77%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
HK$23.66 2.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$81.38 251.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$10.54-54.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.58 338.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.68 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA